KRAS and cancer: We first tested the sensitivity of the Cancer Hotspot Panel v2, which comprises 207 amplicons covering approximately 2,800 COSMIC mutations from 50 cancer genes, to detect hot spot mutations in KRAS, SMAD4, CDKN2A and TP53 [15, 16].